These findings suggest that the expressions of miR-145 and its gene target GOLM1 may serve as potential biomarkers for NSCLC, but indicate that RTKN has no diagnostic value in NSCLC tissues. The gene discussed is GOLM1; the disease is non-small cell lung carcinoma.